OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
We haven't written up this one. OpenAI has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- OpenAI acquires Orchestra Bio openai.com